Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.
about
LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.cAMP responsive element binding protein-1 is a transcription factor of lysosomal-associated protein transmembrane-4 Beta in human breast cancer cellsReversing multidrug resistance in Caco-2 by silencing MDR1, MRP1, MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides.LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.Analysis of single nucleotide polymorphism in adolescent idiopathic scoliosis in Korea: for personalized treatmentLAPTM4B: an oncogene in various solid tumors and its functions.Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.Lysosome-associated protein transmembrane-4β-35 is a novel independent prognostic factor in small cell lung cancer.LAPTM4B*2 allele is associated with the development of papillary thyroid carcinoma in Chinese women.Overexpression of LAPTM4B: an independent prognostic marker in breast cancer.Primary Culture of Undifferentiated Pleomorphic Sarcoma: Molecular Characterization and Response to Anticancer Agents.Association between LAPTM4B gene polymorphism and susceptibility to and prognosis of diffuse large B-cell lymphoma.Association of lysosomal protein transmembrane 4 beta gene polymorphism with pancreatic carcinoma susceptibility in the Chinese population.Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
P2860
Q34235524-5FDCF196-4D3D-463D-9AB0-D50034899134Q34612174-D4E5CF2C-30FA-499F-8405-978A38866F37Q35122908-507DA3AA-CE62-4499-8F2F-EEAFA764D112Q35304103-C7394A93-DF1D-4A87-AB0C-C7D881DFA878Q36620379-D4A2A4C2-5BA1-4CDB-A281-A4C4987217A6Q37510652-549C9B82-011D-42D3-98B7-53760867FA8FQ38801879-AF1C4EE5-0B63-4166-B9FA-98FD28673B93Q41016802-AEF051DC-4F8D-468B-AE76-89B7327789EBQ41616947-31FB5E1F-501B-4FD9-8365-FBF833617CA7Q44123654-33383A8E-46A5-45DF-B5E3-E4878BF88574Q47239615-C6C6F47A-53C5-457D-A460-221704342E6FQ48509293-900888DF-5EE9-4920-85B2-8B9673D20742Q50942673-CB55458D-A0DC-4E4A-A6FF-B4656C3FF494Q53291378-D1A0A30B-3DA4-4407-B454-67345E43B65F
P2860
Overexpression of LAPTM4B-35 attenuates epirubucin-induced apoptosis of gallbladder carcinoma GBC-SD cells.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@ast
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@en
type
label
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@ast
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@en
prefLabel
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@ast
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@en
P2093
P1433
P1476
Overexpression of LAPTM4B-35 a ...... ladder carcinoma GBC-SD cells.
@en
P2093
Jian-Chun Yu
Jing-An Rui
Rou-Li Zhou
Xiao-Dong He
P356
10.1016/J.SURG.2010.12.010
P407
P577
2011-03-23T00:00:00Z